Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -3.14% is 92% above its 5-year average of -40.80%, near the high end of its 5-year range (-786.54%–0.00%).
91.94% above its 12-month average of -38.96%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2025 (2025-12-31): 0.00%.
OPERATING MARGIN
-3.14%
OPERATING MARGIN AVG TTM
-38.96%
OPERATING MARGIN AVG 3Y
-148.02%
OPERATING MARGIN AVG 5Y
-40.80%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+91.94%
CURRENT VS 3Y AVG
+97.88%
CURRENT VS 5Y AVG
+92.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 841 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Moolec Science S.A.
Market Cap
$3.46M
Operating Margin
-3.14%
TTM Avg
-38.96%
3Y Avg
-148.02%
5Y Avg
-40.80%
Market Cap
$3.42M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.58M
Operating Margin
-2781.69%
TTM Avg
-3688.91%
3Y Avg
-3165.01%
5Y Avg
-3029.85%
Market Cap
$3.63M
Operating Margin
0.00%
TTM Avg
-1346.57%
3Y Avg
-8443.50%
5Y Avg
-5629.00%
Market Cap
$3.23M
Operating Margin
-23.11%
TTM Avg
-1618.34%
3Y Avg
-814.04%
5Y Avg
-551.20%
Market Cap
$3.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-518.01%
5Y Avg
-1135.32%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moolec Science S.A. (MLEC) | $3.46M | -3.14% | -38.96% | -148.02% | -40.80% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eocene Ltd. (EOCN)vs › | $3.57M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.58M | -2781.69% | -3688.91% | -3165.01% | -3029.85% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.63M | 0.00% | -1346.57% | -8443.50% | -5629.00% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | -23.11% | -1618.34% | -814.04% | -551.20% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.21M | 0.00% | 0.00% | -518.01% | -1135.32% |
| MBody AI Ltd. (MBAI)vs › | $3.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Evogene Ltd. (EVGN)vs › | $3.79M | -364.24% | -350.71% | -763.84% | -1461.60% |
Gross Margin
34.2%
Operating Margin
-3.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-31 | 0.00% |
| 2024-12-31 | -77.92% |
| 2024-09-30 | -134.97% |
| 2024-06-30 | -193.03% |
| 2024-03-31 | -96.78% |
| 2023-12-31 | -786.54% |
| 2023-09-30 | -130.34% |
| 2023-06-30 | -60.59% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
